Heterozygous PAX6 mutations may lead to hyper‐proinsulinaemia and glucose intolerance: A case–control study in families with congenital aniridia

Wei Tian,Xiao‐Rong Zhu,Chun‐Yan Qiao,Ying‐Nan Ma,Fang‐Yuan Yang,Zhen Zhou,Jian‐Ping Feng,Ran Sun,Rong‐Rong Xie,Jing Lu,Xi Cao,Jian‐Bo Zhou,Jin‐Kui Yang
DOI: https://doi.org/10.1111/dme.14456
IF: 3.5
2020-12-01
Diabetic Medicine
Abstract:<section class="article-section__content"><h3 class="article-section__sub-title section1"> Aim</h3><p><i>PAX6</i> is a transcription factor involved in embryonic development of many organs, including the eyes and the pancreas. Mutations of <i>PAX6</i> gene is the main cause of a rare disease, congenital aniridia (CA). This case‐control study aims to investigate the effects of <i>PAX6</i> mutations on glucose metabolism and insulin secretion in families with CA. </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Methods</h3><p>Twenty‐one families with CA were screened by Sanger sequencing. Patients with <i>PAX6</i> mutations and CA (cases) and age‐matched healthy family members (controls) were enrolled. Oral glucose tolerance test (OGTT) were performed to detect diabetes or impaired glucose tolerance (IGT). Insulin and proinsulin secretion were evaluated. </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Results</h3><p>Among 21 CA families, heterozygous <i>PAX6</i> mutations were detected in five families. Among cases (n=10) from the five families, two were diagnosed with newly identified diabetes and another two were diagnosed with IGT. Among controls (n=12), two had IGT. The level of HbA1c were 36 ± 4 mmol/mol (5.57 ± 0.46 %) and 32 ± 5 mmol/L (5.21 ± 0.54 %) in the cases and the controls, respectively (P = 0.049). More importantly, levels of proinsulin in the cases were significantly higher than that of the controls, despite similar levels of total insulin. The areas under the curve (AUCs) of proinsulin in the cases (6425 ± 4390) were significantly higher than that of the controls (3709 ± 1769) (P = 0.032). </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Conclusion</h3><p><i>PAX6</i> may participate in the production of proinsulin to insulin and heterozygous <i>PAX6</i> mutations may be associated with glucose metabolism in CA patients. </p></section>
endocrinology & metabolism
What problem does this paper attempt to address?